The New Jersey Chamber of Commerce elected eight new members to its board of directors earlier this month.
Chamber CEO and President Tom Bracken said the group represents a wide range of industries, services, nonprofits and advocacy organizations.
"We welcome these respected leaders to the New Jersey Chamber of Commerce board of directors," Bracken said. "Each of them brings a wealth of business experience that will strengthen our board and help us achieve our goal of growing New Jersey's economy and making the state more affordable for everyone."
A look at the new members to the board:
Mike Bukowski, plant manager, Bayway Refinery, Philips 66. A chemical engineer, Bukowski has 24 years of experience in the refining and chemical industries.
Thomas Comiskey, regional president, M&T Bank. Comiskey has 12 years of commercial banking experience, preceded by eight years in international marketing and corporate strategy roles.
Robert Garrett, co-CEO, Hackensack Meridian Health Network. Garrett began his tenure with Hackensack University Medical Center in 1981 as a resident, and served as CEO and president of the Hackensack University Health Network from November 2009 through July 2016, at which time he assumed the position as co-CEO of Hackensack Meridian Health.
Debbie Hart, founding CEO and president, BioNJ. Hart works to ensure a robust life sciences ecosystem in New Jersey. She worked alongside New Jersey's biotechnology industry leaders to establish BioNJ in 1994 and has been pursuing this passion ever since.
Richard Hoefling, vice president, Newark Hub, United. Hoefling oversees the entire operation for Newark Liberty International and La Guardia airports. Combined, he leads a team of more than 13,000 employees.
Ronald Ladell, senior vice president, AvalonBay Communities. Ladell oversees AvalonBay's development activities throughout New Jersey. He has been named to NJBIZ's list of the 75 most influential people in real estate every year since its inception, ranking No. 1 in 2016.
Brian Molloy, president and managing director, Wilentz. Molloy is charged with maintaining the reputation and legacy of one of New Jersey's oldest and most respected law firms.
Joseph Roth, CEO and president, New Jersey Organ and Tissue Sharing Network. Roth manages an organization with more than 150 employees and $37 million in annual revenue. NJ Sharing Network's mission is to save and enhance lives through organ and tissue donation.
Bracken said the board of directors provides the guidance necessary for the New Jersey Chamber to promote a vibrant business climate throughout the state and to develop proactive solutions that will solve the challenges facing New Jersey's business community.